Indonesia · Delayed Price · Currency is IDR IDX:LABS Statistics
Total Valuation
IDX:LABS has a market cap or net worth of IDR 588.55 billion. The enterprise value is 574.89 billion.
| Market Cap | 588.55B |
| Enterprise Value | 574.89B |
Important Dates
The last earnings date was Friday, April 24, 2026.
| Earnings Date | Apr 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IDX:LABS has 3.95 billion shares outstanding.
| Current Share Class | 3.95B |
| Shares Outstanding | 3.95B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 3.29% |
| Owned by Institutions (%) | n/a |
| Float | 960.57M |
Valuation Ratios
The trailing PE ratio is 43.57.
| PE Ratio | 43.57 |
| Forward PE | n/a |
| PS Ratio | 2.95 |
| PB Ratio | 3.86 |
| P/TBV Ratio | 3.98 |
| P/FCF Ratio | 67.79 |
| P/OCF Ratio | 25.71 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.29, with an EV/FCF ratio of 66.22.
| EV / Earnings | 42.56 |
| EV / Sales | 2.88 |
| EV / EBITDA | 17.29 |
| EV / EBIT | 28.23 |
| EV / FCF | 66.22 |
Financial Position
The company has a current ratio of 2.52, with a Debt / Equity ratio of 0.18.
| Current Ratio | 2.52 |
| Quick Ratio | 1.03 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | 0.83 |
| Debt / FCF | 3.17 |
| Interest Coverage | 16.35 |
Financial Efficiency
Return on equity (ROE) is 9.28% and return on invested capital (ROIC) is 10.76%.
| Return on Equity (ROE) | 9.28% |
| Return on Assets (ROA) | 5.90% |
| Return on Invested Capital (ROIC) | 10.76% |
| Return on Capital Employed (ROCE) | 13.06% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 3.69B |
| Profits Per Employee | 250.13M |
| Employee Count | 54 |
| Asset Turnover | 0.92 |
| Inventory Turnover | 1.58 |
Taxes
In the past 12 months, IDX:LABS has paid 4.02 billion in taxes.
| Income Tax | 4.02B |
| Effective Tax Rate | 22.92% |
Stock Price Statistics
The stock price has increased by +29.57% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +29.57% |
| 50-Day Moving Average | 152.58 |
| 200-Day Moving Average | 143.03 |
| Relative Strength Index (RSI) | 38.62 |
| Average Volume (20 Days) | 855,075 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDX:LABS had revenue of IDR 199.30 billion and earned 13.51 billion in profits. Earnings per share was 3.42.
| Revenue | 199.30B |
| Gross Profit | 79.20B |
| Operating Income | 20.37B |
| Pretax Income | 17.52B |
| Net Income | 13.51B |
| EBITDA | 33.01B |
| EBIT | 20.37B |
| Earnings Per Share (EPS) | 3.42 |
Balance Sheet
The company has 41.16 billion in cash and 27.50 billion in debt, with a net cash position of 13.66 billion or 3.46 per share.
| Cash & Cash Equivalents | 41.16B |
| Total Debt | 27.50B |
| Net Cash | 13.66B |
| Net Cash Per Share | 3.46 |
| Equity (Book Value) | 152.46B |
| Book Value Per Share | 38.60 |
| Working Capital | 110.18B |
Cash Flow
In the last 12 months, operating cash flow was 22.89 billion and capital expenditures -14.21 billion, giving a free cash flow of 8.68 billion.
| Operating Cash Flow | 22.89B |
| Capital Expenditures | -14.21B |
| Depreciation & Amortization | 12.64B |
| Net Borrowing | -10.03B |
| Free Cash Flow | 8.68B |
| FCF Per Share | 2.20 |
Margins
Gross margin is 39.74%, with operating and profit margins of 10.22% and 6.78%.
| Gross Margin | 39.74% |
| Operating Margin | 10.22% |
| Pretax Margin | 8.79% |
| Profit Margin | 6.78% |
| EBITDA Margin | 16.56% |
| EBIT Margin | 10.22% |
| FCF Margin | 4.36% |
Dividends & Yields
IDX:LABS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 2.29% |
| FCF Yield | 1.48% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IDX:LABS has an Altman Z-Score of 6 and a Piotroski F-Score of 7.
| Altman Z-Score | 6 |
| Piotroski F-Score | 7 |